Anatole Investment Management’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$47.4M Buy
1,651,701
+50,000
+3% +$1.39M 8.03% 3
2026
Q1
$30M Buy
+1,601,701
New +$30.6M 4.18% 8
2024
Q1
Sell
-665,142
Closed -$20.8M 16
2023
Q4
$20.8M Sell
665,142
-1,436,217
-68% -$51.6M 5.31% 7
2023
Q3
$84.4M Buy
2,101,359
+58,615
+3% +$2.74M 14.26% 2
2023
Q2
$107M Hold
2,042,744
18.98% 2
2023
Q1
$131M Buy
+2,042,744
New +$133M 73.56% 1

Other funds holding STAA

Anatole Investment Management's STAA Position: Q2 2026 in Review

Anatole Investment Management increased its STAAR Surgical (STAA) stake by 3.1% in Q2 2026, buying an estimated $1.39M and bringing the position to 1,651,701 shares worth $47.4M. The position accounts for 8.03% of the portfolio, ranked #3.

Anatole Investment Management first reported a position in STAA in Q1 2023 and has held it in 6 quarters since. The position peaked at $131M in Q1 2023. 200 funds tracked by Wall St. Rank hold STAA as of Q2 2026.

  • Anatole Investment Management held 1,651,701 shares of STAAR Surgical worth $47.4M as of Q2 2026.
  • Anatole Investment Management bought 50,000 STAAR Surgical shares in Q2 2026, an estimated $1.39M.
  • STAAR Surgical made up 8.03% of Anatole Investment Management's portfolio in Q2 2026, its #3 holding.
  • Anatole Investment Management first reported a position in STAAR Surgical in Q1 2023 and has held it in 6 quarters since.
  • Anatole Investment Management's STAAR Surgical position peaked at $131M in Q1 2023.
  • 200 funds tracked by Wall St. Rank held STAAR Surgical as of Q2 2026.

Based on Anatole Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.